Study of Diabetes' Risk Factors and Accelerated Aging According to Socio-economic Status in a Population From the North of France - 3-year Follow-up
PrévenDIAB 2
1 other identifier
observational
2,011
1 country
1
Brief Summary
Populations in precarious situations or with low socio-economic status are at greater risk of diabetes and accelerated ageing. Depending on the population studied, the factors that may explain these health inequalities are not unequivocal and remain poorly understood. Northern France, which is particularly affected by socio-economic disparities, has one of the highest diabetes prevalence rates in mainland France. This is why the researchers wanted to study the clinical, biological, social and behavioral risk factors for the onset of diabetes and accelerated aging in a large population in northern France. A 2021 study aimed to characterize the population (a majority of whom (55%) suffer from precarious conditions) who came to the Institut Pasteur de Lille for their health check-up, in order to study risk factors to better explain these health inequalities. This research consisted of a descriptive observational cross-sectional study carried out on 2233 volunteers (main group) over 18 months, and a complementary analytical case-control study involving 216 participants (sub-group). At present, we are planning a 3-year follow-up of the cohort. Participants will be recontacted for a new health check-up at the Centre d'examen de Santé de l'Institut Pasteur de Lille. At the end of the health check-up, participants will be interviewed by PrévenDIAB study investigators to collect the same data as initially collected, with the exception of some data we deemed unnecessary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2025
CompletedStudy Start
First participant enrolled
March 5, 2025
CompletedFirst Posted
Study publicly available on registry
March 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
March 10, 2025
March 1, 2025
2.7 years
March 4, 2025
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
fasting blood glucose and Hb1Ac
Conversion rate of glycemic status (worsening, stable, improving) according to EPICES score. Prevalence of pre-diabetes/diabetes (T0 and T 3 years) according to EPICES score
Day 0
Secondary Outcomes (4)
Prevalence ratio of (pre)diabetes calculated for clinical, biological and behavioral/environmental explanatory variables
Day 0
Prevalence ratio of (pre) diabetes and accelerated aging according to the socio-economic status
Day 0
Risk (odds Ratio) of (pre) diabetes and accelerated aging according to social, economic, cultural and professional status
Until Day 90
Risk (odds Ratio) of (pre) diabetes and accelerated aging for assessed exposures
Until Day 90
Study Arms (2)
Main Group
observational descriptive cohort
Sub group
Case control study
Interventions
Biological analysis, Physical examination and questionnaires will be performed for all patients of the main group.
In addition to exams for the main group, there will be 2 additional examinations (arterial stiffness) for the patients of the subgroup and others questionnaires.
Eligibility Criteria
Populations in precarious situations or with low socio-economic status are at greater risk of developing diabetes and of accelerated ageing. Depending on the populations studied, the factors that may explain these health inequalities are not unequivocal and remain poorly understood. The Hauts-de-France region, which is particularly affected by socio-economic disparities, has one of the highest prevalence rates of diabetes in mainland France. That's why we want to study the clinical, biological, social and behavioral risk factors for diabetes onset and accelerated aging in a large population in northern France. Our study aims to characterize the population of consultants at the Centre d'Examens de Santé l'Institut Pasteur de Lille, the majority of whom (55%) suffer from precarious conditions, in order to study the risk factors that may better explain these health inequalities. This population will be monitored every 3 years to assess changes in the various parameters.
You may qualify if:
- Participant in the PrévenDIAB study
You may not qualify if:
- Refusal to participate in study
- Scheduling impossible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut Pasteur de Lille, Lille
Hauts de France, 59019, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Philippe FROGUEL
PhD PRECIDIAB
- STUDY DIRECTOR
Matthias VANDESQUILLE
PhD PRECIDIAB
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research prevention center manager
Study Record Dates
First Submitted
March 4, 2025
First Posted
March 10, 2025
Study Start
March 5, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
March 10, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share